Use the menu on the left to view more photos, presentations and videos from past LifeSciences BC events.
Medical Funding Opportunities in the U.S. Department of Defense
November 13, 2012
On November 13, LifeSciences BC and the National Research Council of Canada’s Industrial Research Assistance Program hosted Medical Funding Opportunities in the U.S. Department of Defense. We were pleased to welcome Mr. Dave Hood, a former advisor to the U.S. Army Medical Research and Material Command who outlined the numerous opportunities for funding available to B.C. companies.
The U.S. Department of Defense has been expressing a need for increased research and development yielding medical devices and pharmaceuticals that help address issues experienced by soldiers returning from duty. Many times, the DoD is overlooked by medical device and pharmaceutical companies as a source of investment. A small number of device and pharmaceutical companies have successfully pursued and captured significant funding, which in some cases has included more than $30 million in non-dilutive government funding over several years of product development. In recent months the military medical community, as well as the National Institutes for Health, have begun increasing the available funds and effort in later stage medical device development, production and clinical trials.
Following the workshop, approximately 20 companies had the opportunity for a one-on-one consultation with Mr. Hood to discuss their technologies and find out the best route for them to apply for funding.
Information on these funding programs can be found here:
Regulatory Affairs and Quality Assurance for Medical Devices: Overview, Updates and Q & A
September 18, 2012
Brief presentations were made by each of the panelists followed by a one-hour question and answer period. Key discussion items included definitions of medical devices in the context of the emerging area of wireless health devices, such as mobile apps or remote-sensing pill containers and preparing for FDA audits.
This event was the first installment of a four-part series for our Discovery Foundation BC Excels Program. Thanks to support from the Discovery Parks Foundation, three more sessions will take place in the next six to eight months, and will include IP and finance, clinical regulatory affairs and sales and marketing. Check our calendar here for updates.
View photos from the workshop
View video testimonial from one of our members
Breakfast Speaking Series
June 27, 2012
LifeSciences BC was honoured to have Bruce Ralston, Opposition Critic for Finance and Public Accounts and MLA for Surrey-Whalley as the keynote speaker for our breakfast. Bruce shared his perspective on some of the major issues affecting British Columbia. Prior to Bruce’s speech, Malcolm Kendall, President & CEO of Indel Therapeutics, and Hal Gunn, Co-founder and CEO of Qu Biologics, made brief presentations introducing their respective companies.
From left to right: Malcolm Kendall, President and CEO, Indel Therapeutics, Bruce Ralston, MLA for Surrey-Whalley, Don Enns, President, LifeSciences BC and Hall Gunn, Co-founder and CEO, Qu Biologics
Mingle, mingle, mingle
Canada and eastern Germany – Partners for business success in life sciences
June 5, 2012
LifeSciences BC was pleased to partner with Germany Trade & Invest and the Canadian German Chamber of Industry and Commerce to host a breakfast in Vancouver for Canadian life sciences organizations interested in opportunities in eastern Germany.
Guests heard introductory comments and market overviews from Peter Alltschekow, Director Eastern Germany, Germany Trade & Invest, Don Enns, President, LifeSciences BC, and Omar Oweiss, Senior Manager, Germany Trade & Invest. This was followed by two presentations from companies who have had success doing business in eastern Germany: Dr. Henrich Guntermann, President, Europe and Immunology Group at Nuvo Research and Paul Buck, Chief Financial Officer, STEMCELL Technologies.
For more information or to connect with Germany Trade & Invest and the Canadian German Chamber of Commerce, please visit: http://kanada.ahk.de/en/
Don Enns, President, LifeSciences BC, giving a welcome speech
From left to right: Omar Oweiss, Senior Manager, Germany Trade & Invest, Don Enns, President, LifeSciences BC, Dr. Henrich Guntermann, President, Europe & Immunology Group, Nuvo Research and Peter Alltschekow, Managing Director Marketing & Communications, Director Eastern Germany, Germany Trade & Invest GmbH